Reveal Surgical
Eric Marple has a diverse work experience in the field of biomedical applications. Eric founded EmVision LLC in 2006, a company that specializes in supplying Raman spectroscopic fiber probes and spectrometers. EmVision is internationally recognized for its efficient small form factor in vivo fiber optic probes and high throughput Raman spectrometers. In 2015, Eric co-founded Reveal Surgical, a company based in Montréal, Quebec. Reveal has been assisting surgeons by providing them with data-driven insights into human tissues using AI-enabled optical detection systems. Specifically, their technology, The Sentry System, uses the Raman Effect to help surgeons safely and accurately remove cancerous tissue.
Eric Marple attended Penn State University from 1982 to 1987, where they earned a Bachelor's Degree in Chemical Engineering.
This person is not in any teams
This person is not in any offices
Reveal Surgical
Reveal Surgical is a medical equipment manufacturing company. They develop AI-driven tissue characterization technology, empowering surgeons to identify cancerous tissue in vivo, within seconds, and with unprecedented sensitivity, specificity, and accuracy. Reveal can detect and identify cancer that does not appear using any other imagingmodalities, allowing the surgeon to differentiate between cancerous and healthy tissue during surgery in real-time.